Bantam Pharmaceutical, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bantam Pharmaceutical, LLC.The latest application filed is for "methods for making thiazolypyrazole carboxylic acids and intermediates therefor".

Company Profile

5.8.7

Bantam Pharmaceutical, LLC - New York NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Making Thiazolypyrazole Carboxylic Acids And Intermediates Therefor App 20220267314 - Cooper; Alan ; et al.	2022-08-25
Crystalline Polymorphs Of A 1-thiazol-2-yl-pyrazole-5-carboxylic Acid Derivative App 20220162204 - Cooper; Alan ; et al.	2022-05-26
Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases Grant 11,325,903 - Siddiqui , et al. May 10, 2	2022-05-10
Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases Grant 11,192,887 - Siddiqui , et al. December 7, 2	2021-12-07
Methods Of Treatment Of Cancer With Substituted Pyrrole And Pyrazole Compounds And Diagnosis Of Cancers Susceptible To Treatment With Substituted Pyrrole And Pyrazole Compounds App 20210278408 - Kostura; Matthew ; et al.	2021-09-09
Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment App 20200261424 - Siddiqui; M. Arshad ; et al.	2020-08-20
Methods of Using Substituted Pyrazole and Pyrazole Compounds and for Treatment of Hyperproliferative Diseases App 20200069656 - Siddiqui; Arshad M. ; et al.	2020-03-05
Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto Grant 10,537,558 - Siddiqui , et al. Ja	2020-01-21
Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative Diseases App 20190345152 - Siddiqui; Arshad M. ; et al.	2019-11-14
Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment of Diseases and Disorders Relating Thereto App 20180311218 - Siddiqui; M. Arshad ; et al.	2018-11-01
Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E Grant 9,409,901 - Patane August 9, 2	2016-08-09

Company Registrations

NCAGE Code	7RLY1	BANTAM PHARMACEUTICAL, LLC
CAGE Code	7RLY1	BANTAM PHARMACEUTICAL, LLC
S.A.M. Registration	7RLY1 [80461269]	BANTAM PHARMACEUTICAL, LLC
SEC	0001650608	Bantam Pharmaceutical, LLC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.